Article info
PDFIschemic stroke
Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis
- Correspondence to Elad I Levy, University at Buffalo Neurosurgery, Millard Fillmore Gates Hospital, Kaleida Health, 3 Gates Circle, Buffalo, NY 14209, USA; elevy{at}ubns.com
Citation
Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis
Publication history
- Received October 30, 2009
- Revised December 15, 2009
- Accepted December 18, 2009
- First published May 27, 2010.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.